Image 01
Cisatracurium Besylate Injection
Product Images NDC 0781-3152
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Cisatracurium Besylate (NDC 0781-3152). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Sandoz Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Image 02
This appears to be a numerical data related to a map, indicating different percentages at various coordinates or locations. However, without additional context or visual representation, it is not possible to draw any meaningful conclusions or provide a more specific description.*
Image 03
This text appears to show some percentage increments and decrements related to human resources (HR). However, without additional context or information, it is difficult to determine the specific meaning or relevance of these percentages.*
Image 04
This is a description of a drug called Cisatracurium Besylate Injection, USP. The drug is intended for intravenous injection and is used as a paralyzing agent. It comes in two strengths, 20mg/0mL and 20mg/10mL. The drug must be refrigerated and protected from light. Each mL of Cisatracurum Besylate contains bonzy alcohol 0.9% and War for Infciion USP. Additionally, the drug contains bonzenesulfonic aci s to adjust the ph value. It is manufactured by Gland Pharma Limited in India for Sandoz Inc. Princeton. The usual dosage of the drug is specified in the package insert. Warning issues: causes respiratory arrest and must be administered with the immediate availability of an artificial respiratory facility.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
